KYLE MCCARTHY: Open Payments
NPI 1346693504 · CANTON, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$963 in 52 payments from 18 companies in 2025. Trend: 2023 $770 · 2024 $736 · 2025 $963
Food & beverage: $963
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $268 |
| Otsuka America Pharmaceutical, Inc. | 4 | $97 |
| AstraZeneca Pharmaceuticals LP | 4 | $83 |
| Axsome Therapeutics, Inc. | 3 | $80 |
| Novo Nordisk Inc | 3 | $66 |
| Lilly USA, LLC | 3 | $51 |
| Collegium Pharmaceutical, Inc. | 2 | $40 |
| Verona Pharma, Inc. | 2 | $40 |
| GlaxoSmithKline, LLC. | 2 | $39 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $37 |
Products named: VRAYLAR, REXULTI, Auvelity, JARDIANCE, QULIPTA, Jornay PM, Ohtuvayre, UBRELVY.
Industry payments across IL — which companies pay providers there.
